Última actualización :
08/05/2024
Infostab
Lista de la molécula
Listas recapitulativas
Búsqueda de compatibilidades
Tabla de compatibilidad en Y
Bibliografía
Los equipos de investigación
Valistab
Póster
Vínculos
Patrocinadores
Autores
Manual de instruciones
Boletín de noticias
Hydrochlorothiazide
Estructura química
Bibliografía : Hydrochlorothiazide
Tipo
Publicación
2435
Periódico
Allen LV, Jr, Erickson MA,
Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids
Am J Health-Syst Pharm 1996 ; 53: 2304-2309.
3361
Periódico
Santovena A, Hernandez-Paiz Z, Farina J.B.
Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide.
Int J Pharm 2012 ; 423: 360-364.
3399
Póster
Li Y.Y, Postma D.J, Wagenaar H.W.G.
Development of a hydrochlorothiazide 0.5 mg/mL oral solution for children.
EAHP Congress Paris 2013
3910
Periódico
Polonini H.C, Silva S .L, de Almeida T.R, Brand?o M.A, Ferreira A.O.
Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.
EJHP 2016 ; 23: 352-358.
4177
Periódico
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526
4198
Periódico
Uriel M, Gomez-Rincon C, Marro D.
Stability of regularly prescribed oral liquids formulated with SyrSpend® SF.
Pharmazie 2018 73;196-201
4256
Periódico
Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A.
Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients.
Pharmaceutics 2019 ;11,190:
Mentions Légales
